A detailed history of Ameriprise Financial Inc transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 15,300 shares of AKYA stock, worth $38,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,300
Previous 19,700 22.34%
Holding current value
$38,862
Previous $46,000 10.87%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.96 - $2.94 $8,624 - $12,936
-4,400 Reduced 22.34%
15,300 $41,000
Q2 2024

Aug 14, 2024

SELL
$1.94 - $4.56 $29,391 - $69,084
-15,150 Reduced 43.47%
19,700 $46,000
Q1 2024

May 15, 2024

SELL
$4.33 - $6.06 $22,407 - $31,360
-5,175 Reduced 12.93%
34,850 $163,000
Q4 2023

Feb 14, 2024

SELL
$3.13 - $5.13 $16,589 - $27,189
-5,300 Reduced 11.69%
40,025 $195,000
Q3 2023

Nov 14, 2023

BUY
$4.24 - $7.44 $85,542 - $150,102
20,175 Added 80.22%
45,325 $210,000
Q2 2023

Aug 14, 2023

SELL
$5.28 - $8.35 $5,316 - $8,408
-1,007 Reduced 3.85%
25,150 $185,000
Q1 2023

May 15, 2023

SELL
$7.6 - $12.68 $112,100 - $187,030
-14,750 Reduced 36.06%
26,157 $213,000
Q3 2022

Nov 14, 2022

SELL
$10.63 - $15.76 $73,634 - $109,169
-6,927 Reduced 14.48%
40,907 $480,000
Q2 2022

Aug 15, 2022

SELL
$8.38 - $12.85 $405,407 - $621,657
-48,378 Reduced 50.28%
47,834 $614,000
Q1 2022

May 16, 2022

SELL
$9.84 - $14.97 $5,854 - $8,907
-595 Reduced 0.61%
96,212 $1.06 Million
Q4 2021

Feb 14, 2022

BUY
$11.37 - $15.31 $583,394 - $785,556
51,310 Added 112.78%
96,807 $1.48 Million
Q3 2021

Nov 15, 2021

BUY
$13.04 - $21.0 $48,313 - $77,805
3,705 Added 8.87%
45,497 $635,000
Q2 2021

Aug 16, 2021

BUY
$17.89 - $26.05 $747,658 - $1.09 Million
41,792 New
41,792 $808,000

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $96.2M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.